Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England

被引:145
|
作者
van Hoek, Albert Jan [1 ]
Sheppard, Carmen L. [2 ]
Andrews, Nick J. [1 ]
Waight, Pauline A. [1 ]
Slack, Mary P. E. [2 ]
Harrison, Timothy G. [2 ]
Ladhani, Shamez N. [1 ]
Miller, Elizabeth [1 ]
机构
[1] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England
[2] Publ Hlth England, Resp & Vaccine Preventable Bacteria Reference Uni, London NW9 5EQ, England
关键词
Nasopharynx; Carriage; Colonisation; Streptococcus pneumoniae; Pneumococcus; Conjugate vaccine; Vaccine impact; Post-PCV13; Herd immunity; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; SEROTYPE REPLACEMENT; 13-VALENT; IMMUNOGENICITY; DISEASE;
D O I
10.1016/j.vaccine.2014.03.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background/Aims: In April 2010 the 7-valent pneumococcal conjugate vaccine (PCV7) was replaced by the 13-valent PCV. We investigated pneumococcal carriage in children eligible for PCV7 or PCV13 and their household contacts. Methods: Eligible families in Hertfordshire and Gloucester were identified and a nasopharyngeal swab obtained from consenting household members between July 2012 and March 2013. Samples were cultured for Streptococcus pneumoniae and serotyped by standard methods. For each serotype the ratio of its prevalence in invasive pneumococcal disease (IPD) to its carriage prevalence (case:carrier ratio, CCR) was calculated. Results were compared with previous carriage studies in 2001/2002 and 2008/2009, before and after PCV7 introduction. Results: 217 households were included. Among <5-year olds 47.7% (95% confidence interval 41.8-53.5) were carrying a pneumococcus compared with 51.0% (95% CI: 44.0-58.0) in 2008/2009 and 48.4% (95% CI: 44.1-52.7) in 2001/2002. The odds of carrying a PCV7 serotype was significantly reduced in 2008/2009 (0.07,95% CI: 0.03-0.16) and 2012/2013 (0.01 95% CI: 0.00-0.07) relative to 2001/2002, while the odds of carrying any of the extra six PCV13 serotypes increased after PCV7 introduction (1.38, 95%CI: 0.73-2.59) but declined significantly after PCV13 introduction (0.05, 95%CI: 0.01-0.37). The CCRs for the frequently carried serotypes were relatively low, with the highest CCR observed for serotypes 7F, 19A, 3, 8, and 33F. Across the three carriage studies, CCR estimates were stable for nearly all serotypes. Conclusion: Carriage of additional PCV13 serotypes has rapidly reduced post-PCV13 introduction in both vaccinated and unvaccinated individuals with a continued decline in transmission of PCV7 serotypes. Carriage rates in children remain unchanged, but the low CCRs of replacing serotypes would be expected to further reduce overall IPD across all age groups. (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码:4349 / 4355
页数:7
相关论文
共 50 条
  • [21] Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine
    Kaplan, Sheldon L.
    Barson, William J.
    Lin, Philana Ling
    Romero, Jose R.
    Bradley, John S.
    Tan, Tina Q.
    Hoffman, Jill A.
    Givner, Laurence B.
    Mason, Edward O., Jr.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (03) : 203 - 207
  • [22] Pneumococcal Carriage, Serotype Distribution, and Risk Factors in Children With Community-Acquired Pneumonia, 5 Years After Introduction of the 10-Valent Pneumococcal Conjugate Vaccine in Ethiopia
    Negash, Abel Abera
    Asrat, Daniel
    Abebe, Workeabeba
    Hailemariam, Tewodros
    Gebre, Meseret
    Verhaegen, Jan
    Aseffa, Abraham
    Vaneechoutte, Mario
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (06):
  • [23] Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016
    Makwana, Ashley
    Sheppard, Carmen
    Borrow, Ray
    Fry, Norman
    Andrews, Nick J.
    Ladhani, Shamez N.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (07) : 697 - 703
  • [24] Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain
    Camara, Jordi
    Maria Marimon, Jose
    Cercenado, Emilia
    Larrosa, Nieves
    Quesada, Maria Dolores
    Fontanals, Dionisia
    Cubero, Meritxell
    Perez-Trallero, Emilio
    Fenoll, Asuncion
    Linares, Josefina
    Ardanuy, Carmen
    PLOS ONE, 2017, 12 (04):
  • [25] Impact of 13-valent Pneumococcal Conjugate Vaccine on Pneumococcal Nasopharyngeal Carriage in Children With Acute Otitis Media
    Cohen, Robert
    Levy, Corinne
    Bingen, Edouard
    Koskas, Marc
    Nave, Isabelle
    Varon, Emmanuelle
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (03) : 297 - 301
  • [26] Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
    Gladstone, Rebecca A.
    Jefferies, Johanna M.
    Faust, Saul N.
    Clarke, Stuart C.
    EXPERT REVIEW OF VACCINES, 2012, 11 (08) : 889 - 902
  • [27] Pneumococcal meningitis in adults in 2014–2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan
    Bin Chang
    Kosuke Tamura
    Hiroyuki Fujikura
    Hiroshi Watanabe
    Yoshinari Tanabe
    Koji Kuronuma
    Jiro Fujita
    Kengo Oshima
    Takaya Maruyama
    Shuichi Abe
    Kei Kasahara
    Junichiro Nishi
    Tetsuya Kubota
    Yuki Kinjo
    Yusuke Serizawa
    Reiko Shimbashi
    Munehisa Fukusumi
    Tomoe Shimada
    Tomimasa Sunagawa
    Motoi Suzuki
    Kazunori Oishi
    Scientific Reports, 12
  • [28] Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, Mongolia
    von Mollendorf, Claire
    Mungun, Tuya
    Ulziibayar, Munkhchuluun
    Skoko, Paige
    Boelsen, Laura
    Nguyen, Cattram
    Batsaikhan, Purevsuren
    Suuri, Bujinlkham
    Luvsantseren, Dashtseren
    Narangerel, Dorj
    Tsolmon, Bilegtsaikhan
    Demberelsuren, Sodbayar
    Ortika, Belinda D.
    Pell, Casey L.
    Wee-Hee, Ashleigh
    Nation, Monica L.
    Hinds, Jason
    Dunne, Eileen M.
    Mulholland, E. Kim
    Satzke, Catherine
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [29] Effect of 10-Valent Pneumococcal Conjugate Vaccine on Streptococcus pneumoniae Nasopharyngeal Carriage Among Children Less Than 5 Years Old: 3 Years Post-10-Valent Pneumococcal Conjugate Vaccine Introduction in Mozambique
    Valenciano, Sandra J.
    Moiane, Benild
    Lessa, Fernanda C.
    Chauque, Alberto
    Massora, Sergio
    Pimenta, Fabiana C.
    Mucavele, Helio
    Verani, Jennifer R.
    Carvalho, Maria da Gloria
    Whitney, Cynthia G.
    Tembe, Nelson
    Sigauque, Betuel
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2021, 10 (04) : 448 - 456
  • [30] Invasive Pneumococcal Disease 3 Years After the Introduction of the 13-Valent Conjugate Vaccine in the Oxfordshire Region of England
    Tan, Tina Q.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (07): : 999 - 1000